Literature DB >> 17109593

Dynamic modeling of free fatty acid, glucose, and insulin: an extended "minimal model".

Anirban Roy1, Robert S Parker.   

Abstract

BACKGROUND: The mathematical models for patients with diabetes proposed in the literature since the late 1970s are mainly glucocentric (glucose-based); hence, the contribution of free fatty acid (FFA) metabolism in the body and its glucose-insulin interactions have been largely ignored. However, approximately 90% of the muscle energy is derived from FFA metabolism when the body is at rest. Furthermore, significant interactions exist among FFA, glucose, and insulin. With the long-term goal of developing a closed-loop glucose control system, a model of the major energy-providing substrate dynamics is required.
METHODS: The Bergman minimal model was extended to include plasma FFA dynamics, and its interaction with glucose and insulin dynamics, with a primary focus on patients with Type 1 diabetes. Differential equations were developed for plasma FFA concentrations and "remote" FFA effects on glucose uptake, as well as "remote" insulin effects on plasma FFA concentrations. Parameters for the model were estimated from experimental data provided in the scientific literature.
RESULTS: The minimal model was extended in order to capture three major metabolic aspects: the antilipolytic effect of insulin; the lipolytic effect of prolonged hyperglycemia; and the impairing effect of FFA on glucose uptake rate. The dynamic fit of glucose, FFA, and insulin profiles is consistent with published data.
CONCLUSIONS: The extended minimal model successfully captured the plasma FFA concentration behavior, the plasma insulin and glucose concentrations, and the physiological interactions that exist among these species. This more comprehensive description of energy-providing substrate dynamics may provide a novel simulation test-bed for analysis of patients with insulin dependent diabetes and controller design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109593     DOI: 10.1089/dia.2006.8.617

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  30 in total

1.  Modeling the effects of subcutaneous insulin administration and carbohydrate consumption on blood glucose.

Authors:  Matthew W Percival; Wendy C Bevier; Youqing Wang; Eyal Dassau; Howard C Zisser; Lois Jovanovič; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  Insulin activation of plasma nonesterified fatty acid uptake in metabolic syndrome.

Authors:  Maria A Ramos-Roman; Smadar A Lapidot; Robert D Phair; Elizabeth J Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

Review 3.  The future of open- and closed-loop insulin delivery systems.

Authors:  Terry G Farmer; Thomas F Edgar; Nicholas A Peppas
Journal:  J Pharm Pharmacol       Date:  2008-01       Impact factor: 3.765

4.  Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.

Authors:  Uche Ezeh; Zorayr Arzumanyan; Daria Lizneva; Ruchi Mathur; Yen-Hao Chen; Raymond C Boston; Y-D Ida Chen; Ricardo Azziz
Journal:  Hum Reprod       Date:  2019-02-01       Impact factor: 6.918

5.  Hostility and minimal model of glucose kinetics in African American women.

Authors:  Richard S Surwit; James D Lane; David S Millington; Haoyue Zhang; Mark N Feinglos; Sharon Minda; Rhonda Merwin; Cynthia M Kuhn; Raymond C Boston; Anastasia Georgiades
Journal:  Psychosom Med       Date:  2009-06-26       Impact factor: 4.312

6.  Control Limitations in Models of T1DM and the Robustness of Optimal Insulin Delivery.

Authors:  Christopher Townsend; Maria M Seron; Graham C Goodwin; Bruce R King
Journal:  J Diabetes Sci Technol       Date:  2018-07-31

Review 7.  Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes.

Authors:  Elin Nyman; Yvonne J W Rozendaal; Gabriel Helmlinger; Bengt Hamrén; Maria C Kjellsson; Peter Strålfors; Natal A W van Riel; Peter Gennemark; Gunnar Cedersund
Journal:  Interface Focus       Date:  2016-04-06       Impact factor: 3.906

Review 8.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 9.  Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges.

Authors:  Robert S Parker; Gilles Clermont
Journal:  J R Soc Interface       Date:  2010-02-10       Impact factor: 4.118

10.  Nonlinear modeling of the dynamic effects of infused insulin on glucose: comparison of compartmental with Volterra models.

Authors:  Georgios D Mitsis; Mihalis G Markakis; Vasilis Z Marmarelis
Journal:  IEEE Trans Biomed Eng       Date:  2009-06-02       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.